Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.

Inclusion Criteria

• •1. Individuals in accordance with indications for XLGB Pill, including symptoms of osteoporosis;
• •2. The age range of 18 to 70 years；
• •3. Individuals taking XLGB Pill over 2 weeks;
• •4. Abnormalities of serum liver biochemistry achieving one of the criteria as follows:
• •(i) alanine aminotransaminase (ALT) or aspartate transaminase (AST) ≥2 folds of upper limit of normal (ULN); (ii) total bilirubin (TBiL) ≥ 2 ULN; (iii) alkaline phosphatase (ALP) ≥ 2 ULN;
• •5. Individuals can provide informed consent form.